1
Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer
Condition(s):Castration-resistant Prostate CancerLast Updated:November 8, 2022Active, not recruiting
Abiraterone Acetate: 267 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
Condition(s):Salivary Glands TumorsLast Updated:March 3, 2021Completed
3
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
Condition(s):Abiraterone Acetate; Gene Polymorphism; Pharmacokinetic; Metabolic Analysis; Plasma ConcentrationLast Updated:January 3, 2022Active, not recruiting
4
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Condition(s):21-hydroxylase DeficiencyLast Updated:February 28, 2014Completed
5
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Condition(s):Prostate CancerLast Updated:August 18, 2022Withdrawn
6
Abiraterone Post Ketoconazole for Prostate Cancer
Condition(s):Prostate CancerLast Updated:January 8, 2018Completed
7
Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male Participants
Condition(s):HealthyLast Updated:January 20, 2016Completed
8
A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer
Condition(s):Castrate-resistant Prostate CancerLast Updated:March 27, 2018Terminated
9
Abiraterone Acetate in Combination With Tildrakizumab
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:April 29, 2022Recruiting
10
Abiraterone Acetate Trial in African American Prostate Cancer Patients
Condition(s):Prostate CancerLast Updated:May 12, 2017Terminated